rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2006-11-20
|
pubmed:abstractText |
The purpose of this study was to evaluate the effects of the conversion from azathioprine (AZA) to mycophenolate mofetil (MMF) followed by calcineurin inhibitor (CNI) elimination or minimization in patients with progressive chronic allograft dysfunction (CAD).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0041-1345
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2872-8
|
pubmed:meshHeading |
pubmed-meshheading:17112853-Adult,
pubmed-meshheading:17112853-Azathioprine,
pubmed-meshheading:17112853-Chronic Disease,
pubmed-meshheading:17112853-Ethnic Groups,
pubmed-meshheading:17112853-Female,
pubmed-meshheading:17112853-Follow-Up Studies,
pubmed-meshheading:17112853-Graft Rejection,
pubmed-meshheading:17112853-Humans,
pubmed-meshheading:17112853-Immunosuppressive Agents,
pubmed-meshheading:17112853-Kidney Failure, Chronic,
pubmed-meshheading:17112853-Kidney Transplantation,
pubmed-meshheading:17112853-Male,
pubmed-meshheading:17112853-Middle Aged,
pubmed-meshheading:17112853-Mycophenolic Acid,
pubmed-meshheading:17112853-Prednisone,
pubmed-meshheading:17112853-Time Factors,
pubmed-meshheading:17112853-Transplantation, Homologous
|
pubmed:year |
2006
|
pubmed:articleTitle |
Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction.
|
pubmed:affiliation |
Nephrology Division, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, São Paulo, Brazil.
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|